火星文

리벨리온, 영국에 AI랙 100대 이상 공급 추진…유럽 AI인프라 공략_我的网站

A |     [이 기사에 나온 스타트업에 대한 보다 다양한 기업정보는 유니콘팩토리 빅데이터 플랫폼 ‘데이터랩’에서 볼 수 있습니다.]                   /사진제공=리벨리온AI(인공지능) 반도체 스타트업 리벨리온이 26일 영국의 이기종 AI 컴퓨팅 스타트업 칼로섬(Callosum)과 협업해 영국의 AI 연구 클러스터에 100대 이상의 AI 랙 제품 공급을 추진한다고 밝혔다.칼로섬은 AI 모델과 AI 반도체를 함께 최적화해 사용자가 요청한 작업을 가장 적합한 하드웨어에 자동 배분하는 소프트웨어를 개발하는 스타트업이다. 이를 통해 복잡한 엔지니어링 작업 없이도 최첨단 AI 모델이 요구하는 수준의 성능을 구현한다. 최근 영국 정부의 소버린 AI 펀드 등에서 1억달러(1400억원)의 시드 투자를 유치하며 성장 가능성을 인정받았다.양사는 협업의 첫 단계로 영국 정부가 지원하는 AI 연구 클러스터에 리벨리온의 AI 랙 제품 100대 이상 공급을 추진하기로 했다. AI 랙은 여러 대의 NPU(신경망처리장치) 서버가 탑재된 캐비닛 형태의 인프라다. 칼로섬은 고객에게 별도 최적화 없이 리벨리온의 NPU를 활용할 수 있는 환경을 제공하기로 했다.리벨리온 측은 양사의 협력이 국경을 넘는 민관 협력을 통한 소버린 AI 실현이라고 강조했다. 양사 모두 각국 정부가 조성한 소버린 AI 펀드의 핵심 투자 기업이자, 국가 프로젝트에 주도적으로 참여하는 기업이다. 이에 양사의 파트너십은 정부의 정책적 의지와 스타트업의 기술력이 결합한 모델이라는 설명이다.박성현 리벨리온 대표는 "칼로섬과의 협업은 리벨리온이 외연을 확장하고 소버린 AI 시장 공략에 보다 속도를 낼 수 있는 중요한 전환점"이라며 "성능과 효율, 그리고 안정적인 공급망까지 갖춘 인프라를 제공하는 키 플레이어가 될 것"이라고 말했다.다니얼 아카르카 칼로섬 대표는 "AI의 본질은 개별 칩이 아닌 특화된 여러 시스템 간의 '연합'에서 나온다"며 "리벨리온의 NPU는 칼로섬의 이기종 오케스트레이션 플랫폼에서 핵심 축 역할을 담당하게 될 것"이라고 말했다. 그러면서 "다양한 AI 추론 작업의 성능과 전력 효율을 극대화해 유럽과 아시아를 넘어 글로벌 시장에서 양사의 솔루션을 함께 구축해 나가길 기대한다"고 덧붙였다.[머니투데이 스타트업 미디어 플랫폼 유니콘팩토리]。    Sputnik spoke with Dr. D. B. Bhaaskara, CEO of the multinational company Roerich Healthcare, about the current state of pharma trade with Russia.,Sputnik: Can you explain the current state of pharma supplies to Russia?,D. B. Bhaaskara: Currently, pharmaceutical shipments of Indian firms to Russia are at the same level even after the sanctions. But, there are many proposals (supplies) that Russians are not getting from the European Union. Russians are looking for these materials (chemicals, excipients, APIs [Active Pharmaceutical Ingredients]) with several Indian manufacturers. They have to develop links with Indian firms. There are many proposals from Russia - these proposals are under consideration from the Indian side.,Sputnik: There were reports of delayed payments from Russia initially after sanctions. As we see, trade has jumped manifold in the energy and fertilizer sectors. Do you think payment issues have been resolved in other sectors as well?,D. B. Bhaaskara: Several Indian companies have signed contracts in yuan, which means they are ready to receive payment in China's yuan. Still, the preferred mode of settlement is in the Indian rupee. As export procedures closed successfully in USD/euro/INR, Russians set aside yuan contracts.,My company is receiving regular payment without any delay in Indian rupees or USD or sometimes in euros.,Sputnik: What about logistical issues, as sanctions hit the shipping sector?,D. B. Bhaaskara: The logistical issues are still there because few airlines — namely Aeroflot, Emirates, Qatar, and Turkish — are available for transportation. Transportation costs are slightly high because of no regular cargo consignments. They vary between $8-12 per kg compared to $5 per kg in a normal situation.,Cargo sea shipment is still in a mess. The only port in Gujarat accepts Russian shipping. Here again, the container price is very, very high. We have to pay anything between $9,000 - 12,000 for a container. When there was no conflict or sanctions, it was $2,500 per container.,We have tried to send our shipments via Iran. So, from Gujarat port, the shipment reaches an Iranian port, and from there, it goes via road or rail to Moscow. But, it is taking a much longer time. In general, it is supposed to arrive in 30-40 days, but on an experimental basis, some companies sent their materials via the Iran route, [and they are] still on their way even after two months.,Shanghai is very crowded and has also been hit by the pandemic, making it unsuitable for us. So, the only problem right now is logistics; there is no payment issue.,Some Russian companies have an account with European banks operating in Russia dealing in oil and gas payments. Those banks are being used to send money anywhere worldwide, even with sanctions.,Sputnik: Western firms intended to withdraw their operations in Russia in response to Moscow's special military operation. Do you see some significant investments from Indian pharma companies in Russia to fill the vacuum created by the west?,D. B. Bhaaskara: There are long-pending proposals from a couple of governors, such as [in] Volgograd and Kazan, inviting India's major pharma companies to set up manufacturing units in their region. But, due to the pandemic, nothing moved ahead.,A delegation will be going to Russia to explore the opportunities in Russia in July. A few Indian companies, such as Sun Pharma and Advance Pharma, have manufacturing units in Russia doing finished formulations.,Hopefully, some new companies are interested in setting up units there now. But, Russia is looking to scale up raw material manufacturing, e.g., API. For this, much homework related to regulation should be done between the two governments, especially under sanctions.,Also, big companies such as Sun Pharma, Aurbindo, and Dr. Reddy, all with significant exposure to the US market, may try to avoid investing in Russia because they are scared of the risk associated with sanctions.,Medium-scale companies can come forward to set up raw material (API) manufacturing in Russia. However, it is unclear whether Indian workers/professionals can go and work in Russia. Setting up a new unit in unknown topography with a different language and culture is a little complicated. A lot of these questions are unanswered.。

Current article:http://tuc7w4m.runtunpaixufenjuduishuang.pics/ys1qmn1/20260826/9151.html

Published on:17:02:38